[HTML][HTML] Coexistence of plasma cell neoplasia and myelodysplastic syndrome with excess blasts: case reports and literature review

W Yan, XY Qu, H Li, YC Li, Y Li, K Yao… - Annals of Palliative …, 2021 - apm.amegroups.org
Background: The coexistence of plasma cell neoplasia such as multiple myeloma (MM) or
monoclonal gammopathy of underdetermined significance (MGUS) with myeloid neoplasia …

[HTML][HTML] Management of patients with concurrent clonal plasma cell and myeloid disorders: A single center descriptive case series

MJ Hochman, GF Gerber, PH Imus, SA Ali… - Leukemia Research …, 2024 - Elsevier
Both clonal plasma cell and myeloid disorders occur more frequently with age. Patients with
concurrent clonal plasma cell and myeloid disorders (CPCMD) can present clinical and …

[HTML][HTML] Co-occurrence of High-Risk Myelodysplastic Syndrome With a Complex Karyotype/TP53 Mutation and IgG Lambda Monoclonal Gammopathy of …

M Mir, W Aiman, E Baah, G Guron, H Shaaban - Cureus, 2024 - ncbi.nlm.nih.gov
Myelodysplastic syndrome (MDS) represents a group of hematologic disorders marked by
abnormal cellular development in the bone marrow, while monoclonal gammopathy of …

Identification of two independent clones underlying the co‐existence of myelodysplastic syndrome with excess of blasts type 2 and isolated 5q‐and smouldering …

M Quintini, S Arniani, S Ascani, C Camerini… - …, 2020 - Wiley Online Library
This report is dealing with simultaneous diagnosis of Myelodysplastic Syndrome with Excess
of Blasts 2 (MDS‐EB 2) with isolated 5q deletion and Smoldering Multiple Myeloma (SMM) …

[HTML][HTML] Successful Treatment of Concurrently Diagnosed Multiple Myeloma and Myelodysplastic Syndrome With Isolated Del (5q) With Lenalidomide, Bortezomib …

NR Washington, EA Shippey, M Osswald - Cureus, 2021 - ncbi.nlm.nih.gov
Lenalidomide is known to be an effective therapy for multiple myeloma and for
myelodysplastic syndrome (MDS) with isolated del (5q). We report the case of a patient …

[PDF][PDF] Współistnienie dyskrazji komórek plazmatycznych i zespołu mielodysplastycznego—opisy przypadków i przegląd piśmiennictwa

A Gołos, A Paczek, E Lech-Marańda, K Warzocha… - Hematologia, 2017 - core.ac.uk
Wprowadzenie do praktyki klinicznej nowych terapii wpłynęło na istotne wydłużenie
przeżycia chorych na szpiczaka plazmocytowego (PCM). Dłuższa obserwacja pacjentów …

Coexistence of plasma cell dyscrasias and myelodysplastic syndrome—study of cases and review of literature

A Gołos, A Paczek, E Lech-Marańda… - … in Clinical Practice, 2017 - journals.viamedica.pl
The improvement in plasma cell myeloma (PCM) treatment and much longer overall survival
of the patients led to the observation of long-term complications of the therapy. These …